Comparable stake leader
Pardeep Nijhawan
SEC ownership of Edesa Biotech, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001540159.
Disclosed value leader
Pardeep Nijhawan
Comparable rows
39/46
Latest evidence
16 Jun 2026
- Public ticker
- EDSA on Nasdaq
- Parsed ownership sources
-
13D/G, 3/4/5, and 13F
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Pardeep Nijhawan
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
39 of 46
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
Pardeep Nijhawan
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
16 Jun 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001540159
- Issuer location
- Markham
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Edesa Biotech, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Pardeep Nijhawan
Disclosed value leader
Pardeep Nijhawan
Comparable rows
39/46
Latest evidence
16 Jun 2026
13D/G
3/4/5
13F
Lead comparable stake: 20%
7 rows are not safely comparable across share classes.
13D/G row: Pardeep Nijhawan
Showing 1-8 of 46 holder rows.
Quick read
Pardeep Nijhawan leads the comparable SEC ownership view at 20%.
39 of 46 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Pardeep Nijhawan's linked filing trail.
Comparable ownership
Top 5
Pardeep Nijhawan
20%
Velan Capital Investment Manageme...
10%
Rubric Capital Management LP
7.7%
Sirenia Capital Management LP
7.2%
PERCEPTIVE ADVISORS LLC
6.7%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 46 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Pardeep Nijhawan |
13D/G
3/4/5
Chief Executive Officer, Director, 10%+ Owner
|
20%
|
$17,370,773
2,210,022 shares
|
+$1,330,203 | 16 Jun 2026 |
| Velan Capital Investment Management LP |
13F
13D/G
Company
|
10%
from 13D/G
|
$4,327,825
827,500 shares
|
— | 31 Mar 2026 |
| Rubric Capital Management LP |
13D/G
13F
Company
|
7.7%
|
$4,056,250
687,500 shares
|
$0 | 31 Mar 2025 |
| Sirenia Capital Management LP |
13D/G
|
7.2%
|
$3,540,000
600,000 shares
|
$0 | 31 Mar 2026 |
| PERCEPTIVE ADVISORS LLC |
13F
13D/G
Company
|
6.7%
from 13D/G
|
$2,945,740
563,239 shares
|
— | 31 Mar 2026 |
| INTEGRATED CORE STRATEGIES (US) LLC |
13D/G
|
5.4%
|
$4,092,584
520,685 shares
|
$0 | 11 Jun 2026 |
| Stonepine Capital Management, LLC |
13D/G
13F
Company
|
0.3%
|
$177,000
30,000 shares
|
-$3,914,951 | 31 Mar 2026 |
| Point72 Asset Management, L.P. |
13D/G
|
0%
|
$11.8
2 shares
|
-$3,539,988 | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to buying over the last 12 months. Net value: +$226,455.
Buys
$226,455
Insiders: 2
Sells
$0
Insiders: 0
Net
+$226,455
Shares: +85,571
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 85,571
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 85,571 | 0 | $226,455 | $0 | +$226,455 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-16 of 16 reporting-owner rows connected to Edesa Biotech, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
16
Largest Forms 3/4/5 holder
Pardeep Nijhawan
Net 12M change
+$226,455
Latest report
03 Aug 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Pardeep Nijhawan | Chief Executive Officer, Director, 10%+ Owner | $11,477,814 | +$223,315 | +2% | Mixed | 03 Aug 2026 |
| Peter van der Velden | 10%+ Owner | $4,677,490 | Filing P/S | 09 Jan 2023 | ||
| Michael J. Brooks | President | $1,524,435 | +$3,140 | +0.21% | Mixed | 27 May 2026 |
| Peter J. Weiler | Chief Financial Officer | $677,855 | Mixed | 27 May 2026 | ||
| Patrick Marshall | Director | $377,244 | Mixed | 27 May 2026 | ||
| Carlo Sistilli | Director | $261,180 | Mixed | 27 May 2026 | ||
| Sean Arthur MacDonald | Director | $214,712 | Mixed | 27 May 2026 | ||
| Joan Chypyha | Director | $157,051 | Mixed | 27 May 2026 | ||
| Charles V Olson | Director | $156,900 | Mixed | 27 May 2026 | ||
| Da David Liu | Director | $128,140 | Mixed | 27 May 2026 | ||
| Stephen Lemieux | Chief Financial Officer | $45,842 | Mixed | 04 Aug 2023 | ||
| Kathi Niffenegger | Chief Financial Officer | $28,230 | Mixed | 02 Nov 2022 | ||
| Lorin K. Johnson | Director | Mixed | 28 Feb 2022 | |||
| Paul William Pay | Director | Mixed | 28 Feb 2022 | |||
| Frank R. Oakes | Director | Mixed | 20 Jul 2023 | |||
| Jennifer M. Chao | Director | Mixed | 28 Mar 2022 |
Recent insider transactions for Edesa Biotech, Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Pardeep Nijhawan | EDSA | Common Shares | Award | 0.6% | 5,324 | 893,386 | 03 Aug 2026 | Direct | ||
| Pardeep Nijhawan | EDSA | Common Shares | Award | 0.38% | 3,378 | 888,062 | 02 Jul 2026 | Direct | ||
| Pardeep Nijhawan | EDSA | Common Shares | Award | 21% | 153,550 | 884,684 | 16 Jun 2026 | Direct | ||
| Pardeep Nijhawan | EDSA | Common Shares | Award | 0.23% | 1,671 | 731,134 | 01 Jun 2026 | Direct | ||
| Patrick Marshall | EDSA | Common Shares | Award | 36.1% | 19,000 | 71,666 | 27 May 2026 | Direct | ||
| Sean Arthur MacDonald | EDSA | Common Shares | Award | 86.2% | 19,000 | 41,054 | 27 May 2026 | Direct | ||
| Joan Chypyha | EDSA | Common Shares | Award | 172.3% | 19,000 | 30,029 | 27 May 2026 | Direct | ||
| Peter J. Weiler | EDSA | Common Shares | Award | 99.4% | 64,609 | 129,609 | 27 May 2026 | Direct | ||
| Michael J. Brooks | EDSA | Common Shares | Award | 28.5% | 64,609 | 291,479 | 27 May 2026 | Direct | ||
| Carlo Sistilli | EDSA | Common Shares | Award | 62.5% | 19,000 | 49,417 | 27 May 2026 | Direct | ||
| Charles V Olson | EDSA | Common Shares | Award | 172.7% | 19,000 | 30,000 | 27 May 2026 | Direct | ||
| Pardeep Nijhawan | EDSA | Common Shares | Award | 15.3% | 96,913 | 729,463 | 27 May 2026 | Direct | ||
| Da David Liu | EDSA | Common Shares | Award | 345.4% | 19,000 | 24,501 | 27 May 2026 | Direct | ||
| Pardeep Nijhawan | EDSA | Common Shares | Award | 0.18% | 1,159 | 632,550 | 01 May 2026 | Direct | ||
| Pardeep Nijhawan | EDSA | Common Shares | Award | 0.41% | 2,578 | 631,391 | 01 Apr 2026 | Direct | ||
| Pardeep Nijhawan | EDSA | Common Shares | Purchase | 0.16% | 1,000 | 628,813 | 10 Mar 2026 | Direct | ||
| Pardeep Nijhawan | EDSA | Common Shares | Purchase | 2.55% | $39,000 | $3.90 | 10,000 | 402,702 | 05 Mar 2026 | Held by Pardeep Nijhawan Medicine Professional Corporation |
| Pardeep Nijhawan | EDSA | Common Shares | Purchase | 2.61% | $42,560 | $4.26 | 10,000 | 392,702 | 04 Mar 2026 | Held by Pardeep Nijhawan Medicine Professional Corporation |
| Pardeep Nijhawan | EDSA | Common Shares | Purchase | 2.68% | $36,300 | $3.63 | 10,000 | 382,702 | 03 Mar 2026 | Held by Pardeep Nijhawan Medicine Professional Corporation |
| Pardeep Nijhawan | EDSA | Common Shares | Purchase | 0.27% | $2,280 | $2.28 | 1,000 | 372,702 | 02 Mar 2026 | Held by Pardeep Nijhawan Medicine Professional Corporation |
| Pardeep Nijhawan | EDSA | Common Shares | Purchase | 0.32% | $4,000 | $2.00 | 2,000 | 627,813 | 02 Mar 2026 | Direct |
| Pardeep Nijhawan | EDSA | Common Shares | Award | 1.63% | 10,016 | 625,813 | 02 Mar 2026 | Direct | ||
| Pardeep Nijhawan | EDSA | Common Shares | Purchase | 8.78% | $66,696 | $2.22 | 30,000 | 371,702 | 27 Feb 2026 | Held by Pardeep Nijhawan Medicine Professional Corporation |
| Michael J. Brooks | EDSA | Common Shares | Purchase | 0.89% | $3,140 | $1.57 | 2,000 | 226,870 | 26 Feb 2026 | Direct |
| Pardeep Nijhawan | EDSA | Common Shares | Purchase | 3.46% | $32,480 | $1.58 | 20,571 | 615,797 | 26 Feb 2026 | Direct |
| Pardeep Nijhawan | EDSA | Common Shares | Award | 16% | 82,236 | 595,226 | 19 Feb 2026 | Direct | ||
| Pardeep Nijhawan | EDSA | Common Shares | Award | 2.23% | 11,168 | 512,990 | 02 Feb 2026 | Direct | ||
| Pardeep Nijhawan | EDSA | Common Shares | Award | 2.13% | 10,444 | 501,822 | 05 Jan 2026 | Direct | ||
| Pardeep Nijhawan | EDSA | Common Shares | Award | 1.82% | 8,766 | 491,378 | 01 Dec 2025 | Direct | ||
| Pardeep Nijhawan | EDSA | Common Shares | Award | 1.46% | 6,968 | 482,612 | 03 Nov 2025 | Direct | ||
| Pardeep Nijhawan | EDSA | Common Shares | Award | 1.26% | 5,908 | 475,644 | 02 Oct 2025 | Direct | ||
| Pardeep Nijhawan | EDSA | Common Shares | Award | 1.29% | 5,981 | 469,736 | 11 Sep 2025 | Direct |
* marks a reported price that did not pass the local price check.